Why are cases of HIV infections on the rise among girls?

Translate to Spanish or other 102 languages!

Children and adolescents aged 19 years and under account for just 7% of those with HIV, but they make up 15% of those who die from AIDS-related disease. Image for illustration purposes
Children and adolescents aged 19 years and under account for just 7% of those with HIV, but they make up 15% of those who die from AIDS-related disease. Image for illustration purposes
- Advertisement -
  • A new global snapshot from UNICEF finds that the burden of HIV is falling disproportionately on adolescent girls and children in some areas of the world.
  • Children are primarily becoming infected with HIV by contracting it from often adolescent-age mothers, who have acquired the disease as a result of multiple intertwining factors.
  • Children and adolescents aged 19 years and under account for just 7% of those with HIV, but they make up 15% of those who die from AIDS-related disease.

Overall, the incidence of HIV has fallen from what it once was globally. However, a new and troubling “global snapshot” from UNICEF finds that, for adolescent girls and children in many areas, the crisis persists.

Follow the link below to Medical News Today to reads the full story:

https://www.medicalnewstoday.com/articles/why-are-cases-of-hiv-infections-on-the-rise-among-girls

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

$281 Million Unlocked to Bridge the Gap in Rural Medical Access

AUSTIN - Governor Greg Abbott announced the Texas Health and Human Services Commission (HHSC) will receive $281 million in federal funding for the second year of Rural Texas Strong, a five-year initiative to improve rural healthcare throughout the state.

Skin Myths Dermatologists Want You to Stop Believing Immediately

Have you ever wondered what a dermatologist's top skincare recommendations are

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.
- Advertisement -